Stockreport

Cardiff Oncology to Present at Upcoming Investor Conferences in May

Cardiff Oncology, Inc.  (CRDF) 
PDF SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel t [Read more]